Omega Diagnostics Group PLC is a medical diagnostics company. The Company's segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers. For allergy, it offers Allergodip, which is an enzyme immunoassay for the semi-quantitative determination of Specific immunoglobulin E (IgE) in serum or plasma. For anemia, it offers ATHOZYME Ferritin, which is an enzyme-immunoassay (ELISA) test for the detection and quantification of Ferritin in human serum. It offers a range of products for Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), Connective Tissue Disease, Gastrointestinal, and Vasculitis and Renal Disease. Its Fertility Hormones products include PATHOZYME-LH (Luteinizing Hormone), PATHOZYME-Prolactin and PATHOZYME-Oestradiol.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:ODX
- CUSIP: N/A
- Web: N/A
- Market Cap: £28.55 million
- Outstanding Shares: 108,745,000
- 50 Day Moving Avg: GBX 23.22
- 200 Day Moving Avg: GBX 19.83
- 52 Week Range: GBX 15.12 - GBX 28.01
Sales & Book Value:
- Trailing P/E Ratio: 52.450
- P/E Growth: 0.000
- Annual Revenue: £13.43 million
- Price / Sales: 2.13
- Book Value: GBX 0.19 per share
- Price / Book: 1.38
- Average Volume: 126,222 shs.
Frequently Asked Questions for Omega Diagnostics Group Plc (LON:ODX)
What is Omega Diagnostics Group Plc's stock symbol?
Omega Diagnostics Group Plc trades on the London Stock Exchange (LON) under the ticker symbol "ODX."
Where is Omega Diagnostics Group Plc's stock going? Where will Omega Diagnostics Group Plc's stock price be in 2017?
0 brokers have issued 12-month price objectives for Omega Diagnostics Group Plc's stock. Their forecasts range from GBX 28 to GBX 28. On average, they anticipate Omega Diagnostics Group Plc's stock price to reach GBX 28 in the next twelve months. View Analyst Ratings for Omega Diagnostics Group Plc.
Who are some of Omega Diagnostics Group Plc's key competitors?
Some companies that are related to Omega Diagnostics Group Plc include Harvey Nash Group plc (HVN), Zambeef Products Plc (ZAM), Amryt Pharma PLC (AMYT), Begbies Traynor Group plc (BEG), Lombard Risk Management plc (LRM), Churchill Mining Plc (CHL), Castleton Technology PLC (CTP), Abzena PLC (ABZA), Midatech Pharma PLC (MTPH), Wolf Minerals Limited (WLFE), Quarto Group (QRT), Caledonia Mining Corporation Plc Com (CMCL), Monitise Plc (MONI), Prairie Mining Limited (PDZ), Centralnic Group PLC (CNIC), Stadium Group plc (SDM), ITM Power plc (ITM) and GLI Finance Ltd (GLIF).
Who are Omega Diagnostics Group Plc's key executives?
Omega Diagnostics Group Plc's management team includes the folowing people:
- Andrew Shepherd, Chief Executive, Managing Director, Executive Director
How do I buy Omega Diagnostics Group Plc stock?
Shares of Omega Diagnostics Group Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Omega Diagnostics Group Plc's stock price today?
MarketBeat Community Rating for Omega Diagnostics Group Plc (LON ODX)MarketBeat's community ratings are surveys of what our community members think about Omega Diagnostics Group Plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Omega Diagnostics Group Plc stock can currently be purchased for approximately GBX 26.25.
Consensus Ratings for Omega Diagnostics Group Plc (LON:ODX) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||GBX 28|
Analysts' Ratings History for Omega Diagnostics Group Plc (LON:ODX)
(Data available from 5/29/2015 forward)
|4/25/2017||FinnCap||Reiterated Rating||Corporate||GBX 28|
Earnings History for Omega Diagnostics Group Plc (LON:ODX)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Omega Diagnostics Group Plc (LON:ODX)
Current Year EPS Consensus Estimate: $0.84 EPS
Dividend History for Omega Diagnostics Group Plc (LON:ODX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Omega Diagnostics Group Plc (LON:ODX)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Omega Diagnostics Group Plc (LON:ODX)
Latest Headlines for Omega Diagnostics Group Plc (LON:ODX)
Omega Diagnostics Group Plc (ODX) Chart for Monday, May, 29, 2017